ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

NP47924 Cytokine Modulators

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · compiled

Tender information last checkedLast checked 29 Sept 2026, 20:05.

Opportunity overview

Supply of Cytokine Modulators to NHS Scotland.

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Biogen Idec Ltd

Matched by exact name
Shared contract value
£1.7m
Awarded
Not supplied
Contract signed
29 Jan 2025
Suppliers
One of 3 awarded suppliers
Award ID
010054-2025-1
Status
active
Location
Maidenhead, UK, SL6 3UD, United Kingdom

Pfizer Ltd

Matched by exact name
Shared contract value
£1.7m
Awarded
Not supplied
Contract signed
29 Jan 2025
Suppliers
One of 3 awarded suppliers
Award ID
010054-2025-1
Status
active
Location
Tadworth, UK, KT20 7NS, United Kingdom

Sandoz

Match pending…
Shared contract value
£1.7m
Awarded
Not supplied
Contract signed
29 Jan 2025
Suppliers
One of 3 awarded suppliers
Award ID
010054-2025-1
Status
active
Location
Camberley, Surrey, UK, GU15 3YL, United Kingdom

Biogen Idec Ltd

Matched by exact name
Shared contract value
£44.3m
Awarded
Not supplied
Contract signed
29 Jan 2025
Suppliers
One of 4 awarded suppliers
Award ID
010054-2025-2
Status
active
Location
Maidenhead, UK, SL6 3UD, United Kingdom

Celltrion Healthcare United Kingdom Limited

Match pending…
Shared contract value
£44.3m
Awarded
Not supplied
Contract signed
29 Jan 2025
Suppliers
One of 4 awarded suppliers
Award ID
010054-2025-2
Status
active
Location
Slough, UK, SL1 1QP, United Kingdom

Janssen Cilag Limited

Matched by normalised name
Shared contract value
£44.3m
Awarded
Not supplied
Contract signed
29 Jan 2025
Suppliers
One of 4 awarded suppliers
Award ID
010054-2025-2
Status
active
Location
High Wycombe, UK, HP12 4EG, United Kingdom

Sandoz Ltd

Matched by exact name
Shared contract value
£44.3m
Awarded
Not supplied
Contract signed
29 Jan 2025
Suppliers
One of 4 awarded suppliers
Award ID
010054-2025-2
Status
active
Location
Camberley, UK, GU16 7SR, United Kingdom

Accord Healthcare Ltd

Match pending…
Shared contract value
£5.2m
Awarded
Not supplied
Contract signed
29 Jan 2025
Suppliers
One of 2 awarded suppliers
Award ID
010054-2025-3
Status
active
Location
North Harrow, UK, HA1 4HF, United Kingdom

medac Pharma LLP

Matched by exact name
Shared contract value
£5.2m
Awarded
Not supplied
Contract signed
29 Jan 2025
Suppliers
One of 2 awarded suppliers
Award ID
010054-2025-3
Status
active
Location
Stirling, UK, FK9 4NF, United Kingdom

Accord Healthcare Ltd

Match pending…
Contract value
£577k
Awarded
Not supplied
Contract signed
29 Jan 2025
Award ID
010054-2025-5
Status
active
Location
North Harrow, UK, HA1 4HF, United Kingdom

Nordic Pharma Ltd

Match pending…
Contract value
£1k
Awarded
Not supplied
Contract signed
29 Jan 2025
Award ID
010054-2025-6
Status
active
Location
Reading, UK, RG7 4SA, United Kingdom

Nordic Pharma Ltd

Match pending…
Contract value
£15k
Awarded
Not supplied
Contract signed
29 Jan 2025
Award ID
010054-2025-7
Status
active
Location
Reading, UK, RG7 4SA, United Kingdom

Classification

  • CPV33600000 — Pharmaceutical products

Lots

  • Etanercept£11.3m
  • Infliximab IV£5.6m
  • Infliximab SC£1.4m
  • Methotrexate syringes (25mg/1 ml concentration)£57.7k
  • Methotrexate pens (25mg/1ml concentration)£57.5k
  • Methotrexate pens (50mg/1 ml concentration)£4.5m
  • Methotrexate syringes (50mg/1ml concentration)£101.8k

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
ocds-h6vhtk-04b34f
Status
complete
Has Recurrence
No
Review Details
The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued, or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.
Procurement Method
open
Main Procurement Category
goods
Procurement Method Details
Open procedure

Covered By

GPA

Bid Opening

Date
2 Dec 2024, 12:00

Legal basis

Id
32014L0024
Scheme
CELEX

Lot Details

Maximum Lots Bid Per Supplier
9,999,999

Techniques

Has Framework Agreement
Yes

Framework Agreement

Maximum Participants
8

Expected award period

Starts
2 Dec 2024, 12:00

Tender Period

Ends
2 Dec 2024, 12:00

Contract terms

Has Electronic Payment
Yes
Has Electronic Ordering
Yes
Electronic Invoicing Policy
allowed

Classification

Id
33600000
Scheme
CPV
Description
Pharmaceutical products

Submission terms

Languages

en

Submission Method

electronicSubmission

Selection criteria

Criteria

Criterion 1
Type
technical
Minimum
(a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes. (c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products. (d) A completed copy of the Bidder Climate Change Plan Template, including planned projects and actions to reduce the bidder’s carbon emissions should be provided in the Qualification Envelope of the ITT under Environmental Management Criteria. This does not need to contain calculated carbon emissions.
Description
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. (c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design. (d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.

Applies To

supplier

Lots and requirements

Entry 1
Id
1
Title
Etanercept
Status
cancelled
Has Options
No
Has Renewal
Yes
Description
Supply of Etanercept to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.

Value

Amount
11,337,834
Currency
GBP

Renewal

Description
This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Award criteria

Criteria

Criterion 1
Name
API Sources
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Contract period

Duration In Days
720

Submission terms

Variant Policy
notAllowed
Entry 2
Id
2
Title
Infliximab IV
Status
cancelled
Has Options
No
Has Renewal
Yes
Description
Supply of Infliximab IV to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of five (5) Framework Participants.

Value

Amount
5,584,117
Currency
GBP

Renewal

Description
This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Award criteria

Criteria

Criterion 1
Name
API Sources
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Contract period

Duration In Days
720

Submission terms

Variant Policy
notAllowed
Entry 3
Id
3
Title
Infliximab SC
Status
cancelled
Has Options
No
Has Renewal
Yes
Description
Supply of Infliximab SC to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per product line.

Value

Amount
1,364,625
Currency
GBP

Renewal

Description
This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Award criteria

Criteria

Criterion 1
Name
API Sources
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Contract period

Duration In Days
720

Submission terms

Variant Policy
notAllowed
Entry 4
Id
4
Title
Methotrexate syringes (25mg/1 ml concentration)
Status
cancelled
Has Options
No
Has Renewal
Yes
Description
Supply of Methotrexate syringes (25mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.

Value

Amount
57,674
Currency
GBP

Renewal

Description
This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Award criteria

Criteria

Criterion 1
Name
API Sources
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Contract period

Duration In Days
720

Submission terms

Variant Policy
notAllowed
Entry 5
Id
5
Title
Methotrexate pens (25mg/1ml concentration)
Status
cancelled
Has Options
No
Has Renewal
Yes
Description
Supply of Methotrexate pens (25mg/1ml concentration)to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.

Value

Amount
57,473
Currency
GBP

Renewal

Description
This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Award criteria

Criteria

Criterion 1
Name
API Sources
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Contract period

Duration In Days
720

Submission terms

Variant Policy
notAllowed
Entry 6
Id
6
Title
Methotrexate pens (50mg/1 ml concentration)
Status
cancelled
Has Options
No
Has Renewal
Yes
Description
Supply of Methotrexate pens (50mg/1 ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.

Value

Amount
4,459,687
Currency
GBP

Renewal

Description
This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Award criteria

Criteria

Criterion 1
Name
API Sources
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Contract period

Duration In Days
720

Submission terms

Variant Policy
notAllowed
Entry 7
Id
7
Title
Methotrexate syringes (50mg/1ml concentration)
Status
cancelled
Has Options
No
Has Renewal
Yes
Description
Supply of Methotrexate syringes (50mg/1ml concentration) to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of three (3) Framework Participants.

Value

Amount
101,754
Currency
GBP

Renewal

Description
This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Award criteria

Criteria

Criterion 1
Name
API Sources
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Contract period

Duration In Days
720

Submission terms

Variant Policy
notAllowed

Items and delivery

Item 1
Id
1
Related Lot
1

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.

Delivery locations

Entry 1
Region
UKM
Entry 2
Region
UKM

Additional Classifications

Entry 1
Id
33600000
Scheme
CPV
Description
Pharmaceutical products
Item 2
Id
2
Related Lot
2

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.

Delivery locations

Entry 1
Region
UKM
Entry 2
Region
UKM

Additional Classifications

Entry 1
Id
33600000
Scheme
CPV
Description
Pharmaceutical products
Item 3
Id
3
Related Lot
3

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.

Delivery locations

Entry 1
Region
UKM
Entry 2
Region
UKM

Additional Classifications

Entry 1
Id
33600000
Scheme
CPV
Description
Pharmaceutical products
Item 4
Id
4
Related Lot
4

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.

Delivery locations

Entry 1
Region
UKM
Entry 2
Region
UKM

Additional Classifications

Entry 1
Id
33600000
Scheme
CPV
Description
Pharmaceutical products
Item 5
Id
5
Related Lot
5

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.

Delivery locations

Entry 1
Region
UKM
Entry 2
Region
UKM

Additional Classifications

Entry 1
Id
33600000
Scheme
CPV
Description
Pharmaceutical products
Item 6
Id
6
Related Lot
6

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.

Delivery locations

Entry 1
Region
UKM
Entry 2
Region
UKM

Additional Classifications

Entry 1
Id
33600000
Scheme
CPV
Description
Pharmaceutical products
Item 7
Id
7
Related Lot
7

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.

Delivery locations

Entry 1
Region
UKM
Entry 2
Region
UKM

Additional Classifications

Entry 1
Id
33600000
Scheme
CPV
Description
Pharmaceutical products

Buyer, suppliers and contacts

Organisation 1
Id
GB-FTS-115937
Name
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Roles

buyer
centralPurchasingBody

Address

Region
UKM
Locality
Edinburgh
Postal Code
EH12 9EB
Country Name
United Kingdom
Street Address
1 South Gyle Crescent

Details

Classifications

Entry 1
Id
BODY_PUBLIC
Scheme
TED_CA_TYPE
Description
Body governed by public law
Entry 2
Id
07
Scheme
COFOG
Description
Health

Identifier

Legal Name
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Contact

Name
Stephanie McNiven
Telephone
+44 1312756000
Organisation 2
Id
GB-FTS-324
Name
Sheriff Court House

Roles

reviewBody

Address

Locality
Edinburgh
Postal Code
EH1 1LB
Country Name
United Kingdom
Street Address
27 Chambers Street

Details

Identifier

Legal Name
Sheriff Court House

Contact

Telephone
+44 1312252525
Organisation 3
Id
GB-FTS-141106
Name
Biogen Idec Ltd

Roles

supplier

Address

Region
UK
Locality
Maidenhead
Postal Code
SL6 3UD
Country Name
United Kingdom
Street Address
Biogen Building 5 Foundation Park, , Roxborough Way, Maidenhead, Berkshire, England,

Details

Scale
large

Identifier

Legal Name
Biogen Idec Ltd
Organisation 4
Id
GB-FTS-5312
Name
Celltrion Healthcare United Kingdom Limited

Roles

supplier

Address

Region
UK
Locality
Slough
Postal Code
SL1 1QP
Country Name
United Kingdom
Street Address
1-7 The Switch

Details

Scale
large

Identifier

Legal Name
Celltrion Healthcare United Kingdom Limited
Organisation 5
Id
GB-FTS-4550
Name
Accord Healthcare Ltd

Roles

supplier

Address

Region
UK
Locality
North Harrow
Postal Code
HA1 4HF
Country Name
United Kingdom
Street Address
Sage House, 319 Piner Road

Details

Scale
large

Identifier

Legal Name
Accord Healthcare Ltd
Organisation 6
Id
GB-FTS-141107
Name
Nordic Pharma Ltd

Roles

supplier

Address

Region
UK
Locality
Reading
Postal Code
RG7 4SA
Country Name
United Kingdom
Street Address
Abbey House, 1650 Arlington Business Park, Theale

Details

Scale
large

Identifier

Legal Name
Nordic Pharma Ltd
Organisation 7
Id
GB-FTS-95765
Name
Sandoz

Roles

supplier

Address

Region
UK
Locality
Camberley, Surrey
Postal Code
GU15 3YL
Country Name
United Kingdom
Street Address
Park View, Riverside Way, Watchmoor Park

Details

Scale
large

Identifier

Legal Name
Sandoz
Organisation 8
Id
GB-FTS-57454
Name
Pfizer Ltd

Roles

supplier

Address

Region
UK
Locality
Tadworth
Postal Code
KT20 7NS
Country Name
United Kingdom
Street Address
Walton Oaks, Dorking Road

Details

Scale
large

Identifier

Legal Name
Pfizer Ltd
Organisation 9
Id
GB-FTS-107241
Name
Janssen Cilag Limited

Roles

supplier

Address

Region
UK
Locality
High Wycombe
Postal Code
HP12 4EG
Country Name
United Kingdom
Street Address
50-100, Holmers Farm Way

Details

Scale
large

Identifier

Legal Name
Janssen Cilag Limited
Organisation 10
Id
GB-FTS-4558
Name
Sandoz Ltd

Roles

supplier

Address

Region
UK
Locality
Camberley
Postal Code
GU16 7SR
Country Name
United Kingdom
Street Address
Frimley Business Park, Frimley

Details

Scale
large

Identifier

Legal Name
Sandoz Ltd
Organisation 11
Id
GB-FTS-4551
Name
medac Pharma LLP

Roles

supplier

Address

Region
UK
Locality
Stirling
Postal Code
FK9 4NF
Country Name
United Kingdom
Street Address
Scion House, Innovation Park

Details

Scale
large

Identifier

Legal Name
medac Pharma LLP

Award information

Award 1
Id
010054-2025-1
Title
Etanercept
Status
active

Suppliers

Supplier 1
Id
GB-FTS-141106
Name
Biogen Idec Ltd
Supplier 2
Id
GB-FTS-95765
Name
Sandoz
Supplier 3
Id
GB-FTS-57454
Name
Pfizer Ltd

Related lots

1
Award 2
Id
010054-2025-2
Title
Infliximab IV
Status
active

Suppliers

Supplier 1
Id
GB-FTS-5312
Name
Celltrion Healthcare United Kingdom Limited
Supplier 2
Id
GB-FTS-107241
Name
Janssen Cilag Limited
Supplier 3
Id
GB-FTS-141106
Name
Biogen Idec Ltd
Supplier 4
Id
GB-FTS-4558
Name
Sandoz Ltd

Related lots

2
Award 3
Id
010054-2025-3
Title
Methotrexate pens (25mg/1ml concentration)
Status
active

Suppliers

Supplier 1
Id
GB-FTS-4550
Name
Accord Healthcare Ltd
Supplier 2
Id
GB-FTS-4551
Name
medac Pharma LLP

Related lots

5
Award 4
Id
010054-2025-4
Title
Infliximab SC
Status
active

Suppliers

Supplier 1
Id
GB-FTS-5312
Name
Celltrion Healthcare United Kingdom Limited

Related lots

3
Award 5
Id
010054-2025-5
Title
Methotrexate syringes (25mg/1 ml concentration)
Status
active

Suppliers

Supplier 1
Id
GB-FTS-4550
Name
Accord Healthcare Ltd

Related lots

4
Award 6
Id
010054-2025-6
Title
Methotrexate pens (50mg/1 ml concentration)
Status
active

Suppliers

Supplier 1
Id
GB-FTS-141107
Name
Nordic Pharma Ltd

Related lots

6
Award 7
Id
010054-2025-7
Title
Methotrexate syringes (50mg/1ml concentration)
Status
active

Suppliers

Supplier 1
Id
GB-FTS-141107
Name
Nordic Pharma Ltd

Related lots

7

Contracts and changes

Entry 1
Id
010054-2025-1
Title
Etanercept
Status
active
Award ID
010054-2025-1
Date Signed
29 Jan 2025, 00:00

Value

Amount
1,700,000
Currency
GBP
Entry 2
Id
010054-2025-2
Title
Infliximab IV
Status
active
Award ID
010054-2025-2
Date Signed
29 Jan 2025, 00:00

Value

Amount
44,300,000
Currency
GBP
Entry 3
Id
010054-2025-3
Title
Methotrexate pens (25mg/1ml concentration)
Status
active
Award ID
010054-2025-3
Date Signed
29 Jan 2025, 00:00

Value

Amount
5,150,000
Currency
GBP
Entry 4
Id
010054-2025-4
Title
Infliximab SC
Status
active
Award ID
010054-2025-4
Date Signed
29 Jan 2025, 00:00

Value

Amount
4,200,000
Currency
GBP
Entry 5
Id
010054-2025-5
Title
Methotrexate syringes (25mg/1 ml concentration)
Status
active
Award ID
010054-2025-5
Date Signed
29 Jan 2025, 00:00

Value

Amount
577,000
Currency
GBP
Entry 6
Id
010054-2025-6
Title
Methotrexate pens (50mg/1 ml concentration)
Status
active
Award ID
010054-2025-6
Date Signed
29 Jan 2025, 00:00

Value

Amount
1,000
Currency
GBP
Entry 7
Id
010054-2025-7
Title
Methotrexate syringes (50mg/1ml concentration)
Status
active
Award ID
010054-2025-7
Date Signed
29 Jan 2025, 00:00

Value

Amount
15,000
Currency
GBP

Recorded locations

  • Buyer location · Edinburgh · UKM · EH12 9EB · United Kingdom
  • Delivery location · UKM

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. ocds-h6vhtk-04b34f-2025-03-19T09:15:55Zcompiled ·